Abingworth LLP is based out of London. Abingworth LLP is a registered investment advisory firm Whalewisdom has at least 50 13F filings, 52 13D filings, 23 13G filings, and 25 Form 4 filings
2024-09-30
Top Buys (13F)
| Name | % Change |
|---|
2024-09-30
Top Sells (13F)
| Name | % Change |
|---|
2024-09-30
13F Holdings Summary
| Name | $ Change |
|---|---|
| SLNO Soleno Therapeutics | 58.35% |
| PHAT Phathom Pharmaceutic | 17.95% |
| QTTB Q32 Bio Inc | 13.81% |
| JSPR Jasper Therapeutics | 5.65% |
| OKUR OnKure Therapeutics | 1.29% |
All or part of ABINGWORTH LLP 13F disclosures were filed
under a combined 13F through
Carlyle Group Inc.
for 2024-09-30
for 2024-09-30
2024-09-30
13F Activity
| Market Value | $352m, Prior: $318m |
| New Purchases | 0 stocks |
| Added To | 1 stocks |
| Sold out of | 0 stocks |
| Reduced holdings in | 0 stocks |
| Top 10 Holdings % | 99.91% |
| Turnover %[1] | 0% |
| Turnover Alt %[2] | -1.1% |
| Time Held Top 20 | 5.4167 quarters |
| Time Held Top 10 | 4.4 quarters |
| Time Held All | 5.42 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2024-09-30
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data
2024-09-30
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2024-09-30